Blood disorder startup files for $86M IPO

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 19, 2020 at 10:02 AM.

  1. #1 cafead, Feb 19, 2020 at 10:02 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,039
    Likes Received:
    3
    via As competitors narrow in, a blood disorder-focused Cambridge startup is planning to raise more funds through an IPO.

    Imara Inc. hopes to raise $86M in its stock market launch, according to paperwork filed with the SEC. The company plans to trade on Nasdaq using the ticker “IMRA”.

    article source
     
    Quote

Reply to Thread